SomnoMed Limited (ASX: $SOM) has requested a trading halt for its securities on the ASX, pending the release of an announcement. The company aims to provide a trading update and earnings guidance, with the trading halt expected to be lifted upon the announcement's release or by the commencement of trading on Tuesday, 2 April 2024.
The Company has requested a trading halt to ensure that all shareholders and the market are informed simultaneously about the upcoming trading update and earnings guidance. This aligns with our commitment to transparency and fair disclosure of material information. We believe that this trading halt will facilitate an orderly market and enable investors to make well-informed decisions.
SomnoMed Limited (ASX: $SOM) has taken the proactive step of requesting a trading halt to prepare for the release of an important trading update and earnings guidance. This demonstrates the company's dedication to providing timely and transparent information to its shareholders and the market. The upcoming announcement is anticipated to provide valuable insights into the company's performance and future outlook, potentially influencing investment decisions. Shareholders and investors can look forward to the resumption of trading and the release of the awaited announcement, which is expected to contribute to a well-informed market.